Alaunos Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $66.4M | $153.7M | $140.7M |
| FY2016 | $58.3M | $106.3M | $81.1M |
| FY2017 | $58.4M | $105.6M | $70.9M |
| FY2018 | $9.5M | $95.1M | $61.7M |
| FY2019 | $14.1M | $109.1M | $79.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $66.4M | $153.7M | $140.7M |
| FY2016 | $58.3M | $106.3M | $81.1M |
| FY2017 | $58.4M | $105.6M | $70.9M |
| FY2018 | $9.5M | $95.1M | $61.7M |
| FY2019 | $14.1M | $109.1M | $79.7M |